JP2013533874A5 - - Google Patents

Download PDF

Info

Publication number
JP2013533874A5
JP2013533874A5 JP2013517481A JP2013517481A JP2013533874A5 JP 2013533874 A5 JP2013533874 A5 JP 2013533874A5 JP 2013517481 A JP2013517481 A JP 2013517481A JP 2013517481 A JP2013517481 A JP 2013517481A JP 2013533874 A5 JP2013533874 A5 JP 2013533874A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
amount
particles
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013517481A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013533874A (ja
Filing date
Publication date
Priority claimed from FR1055491A external-priority patent/FR2962331B1/fr
Application filed filed Critical
Publication of JP2013533874A publication Critical patent/JP2013533874A/ja
Publication of JP2013533874A5 publication Critical patent/JP2013533874A5/ja
Pending legal-status Critical Current

Links

JP2013517481A 2010-07-06 2011-07-05 薬による化学的服従に対処するための医薬剤形 Pending JP2013533874A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1055491A FR2962331B1 (fr) 2010-07-06 2010-07-06 Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre
FR1055491 2010-07-06
PCT/FR2011/051601 WO2012007672A1 (fr) 2010-07-06 2011-07-05 Forme pharmaceutique pour lutter contre la soumission chimique d'un medicament

Publications (2)

Publication Number Publication Date
JP2013533874A JP2013533874A (ja) 2013-08-29
JP2013533874A5 true JP2013533874A5 (https=) 2014-08-21

Family

ID=43661911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013517481A Pending JP2013533874A (ja) 2010-07-06 2011-07-05 薬による化学的服従に対処するための医薬剤形

Country Status (13)

Country Link
US (2) US20130108556A1 (https=)
EP (1) EP2590632B1 (https=)
JP (1) JP2013533874A (https=)
KR (1) KR20130043180A (https=)
CN (1) CN103118667B (https=)
AU (1) AU2011278140B2 (https=)
CA (1) CA2802404C (https=)
ES (1) ES2733732T3 (https=)
FR (1) FR2962331B1 (https=)
IL (1) IL223887B (https=)
MX (1) MX344018B (https=)
WO (1) WO2012007672A1 (https=)
ZA (1) ZA201300077B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2962550B1 (fr) * 2010-07-06 2013-06-14 Ethypharm Sa Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
FR2787715B1 (fr) * 1998-12-23 2002-05-10 Synthelabo Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables
FR2790387B1 (fr) 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
US20040258750A1 (en) * 1999-06-28 2004-12-23 Gerard Alaux Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
AU2001232020A1 (en) * 2000-02-09 2001-08-20 West Pharmaceutical Services Drug Delivery And Clinical Research Centre Limited Floating drug delivery composition
ITMI20011446A1 (it) * 2001-07-06 2003-01-06 Altergon Sa Composizioni farmaceutiche di principi attivi suscettibili di somministrazione illecita
FR2829932B1 (fr) * 2001-09-21 2006-11-24 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs et produit obtenu
FR2829933B3 (fr) * 2001-09-21 2004-03-12 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
FR2831820B1 (fr) 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
DE10336400A1 (de) * 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20080102482A1 (en) 2003-12-19 2008-05-01 Stanley Irwin Grossman Apparatus for Detecting Drugs in a Beverage
WO2006044805A2 (en) * 2004-10-15 2006-04-27 Supernus Pharmaceuticals, Inc. Less abusable pharmaceutical preparations
EP1681048A1 (en) * 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Orally disintegrating composition of olanzapine or donepezil
FR2892937B1 (fr) * 2005-11-10 2013-04-05 Flamel Tech Sa Forme pharmaceutique orale microparticulaire anti-mesusage
WO2008033351A2 (en) * 2006-09-11 2008-03-20 Theraquest Biosciences, Inc. Multimodal abuse resistant and extended release formulations
BRPI0817927A2 (pt) * 2007-10-01 2015-04-07 Lesvi Laboratorios Sl Comprimidos orodispersiveis
WO2009104080A2 (en) * 2008-02-20 2009-08-27 Targia Pharmaceuticals Cns pharmaceutical compositions and methods of use

Similar Documents

Publication Publication Date Title
ES2286119T3 (es) Composicion de recubrimiento para enmascarar el sabor.
US20150108033A1 (en) Pharmaceutical compositions for poorly soluble active ingredients
ES2593210T3 (es) Composiciones farmacéuticas mejoradas de pimobendán
WO2020044116A1 (en) Therapeutic combinations of cannabinoids with curcumin
CA2873837C (en) Acid resistant banding solution for two piece hard capsules
HRP20241461T1 (hr) Aprocitentan za uporabu u liječenju hipertenzije i povezanih bolesti u kombinaciji s valsartanom
BRPI0808475A2 (pt) Preparação de película de dissolução/desintegração rápida tendo proporção elevada de ativos
WO2009069139A1 (en) Dosage form providing an ibuprofen-containing liquid fill
US20210205236A1 (en) Therapeutic combinations of boswellia extract and cannabinoids
JP2013523676A5 (https=)
JP2013530206A5 (https=)
JPWO2018008660A1 (ja) 硬度が改善された硬質カプセル、及びその製造方法
ES2261006B1 (es) Pellet multicapa de liberacion controlada de metilfenidato.
HRP20192227T1 (hr) Dvojna uporaba oralnog farmaceutskog pripravka tableta sulfatnih soli i metode njihove uporabe
ES2535106T3 (es) Composiciones farmacéuticas de rosuvastatina cálcica
US20210338629A1 (en) Oral formulations of phenylalanine and cannabinoids
ES2240492T3 (es) Soluciones de ibuprofeno para rellenar capsulas y preparaciones de capsulas.
JP2013533874A5 (https=)
JP2013530206A (ja) 飲料中の薬物を検出するための方法および薬剤
WO2013098268A3 (en) Tablets and dry-coated agents
US9827199B2 (en) Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
ES2742034T3 (es) Composición farmacéutica que contiene flurbiprofeno
WO2008147169A2 (es) Microemolsion conteniendo pirfenidona
WO2012131476A1 (en) Composition and method for controlling release of active ingredient
EP3862022B1 (en) Improved-strength hard capsule and production method for same